New “First” Program: Six Months of Free Lab Space for Eligible First-Time Biotech Founders >

Press Releases

HiFiBiO Therapeutics Secures $37.5 Million Series B Financing to Accelerate Pipeline of Novel Antibody Drugs to Treat Cancer and Autoimmune Disorders

May 17, 2018 | By

Share :